News
Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...
Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.
Concerns over new age weight loss, diabetes drugs ...
16h
ScienceAlert on MSNOzempic-Like Drugs Could Treat Chronic Migraines, Trial FindsMedications sold under brand names like Ozempic, Wegovy, and Saxenda have become famous for their weight-loss benefits, but ...
A recent study suggests that liraglutide, a drug similar to Ozempic, may reduce migraine frequency in obese individuals with ...
A GLP-1 drug led to fewer days with headaches, a small pilot study of migraine sufferers shows. It may work by lowering pressure inside the head.
Senior Advocate Diya Kapur, representing the petitioner, informed the court that some gyms were promoting these drugs as a ...
The Delhi High Court has instructed India's drug regulator to address concerns about the approval process for drugs like ...
The UK's medicines regulator has launched a study to investigate the impact of these drugs following reports of people dying ...
2d
NDTV Profit on MSNDelhi HC Directs DCGI To Decide On Plea Flagging Concerns Over Approvals Of Weight Loss DrugsThe plea alleged that licences for these drugs were given without appropriate scientific trials, data or noted potential ...
The company is seeking regulatory approval of generic Ozempic by September from Canadian authorities, along with other ...
The proceedings follow a PIL seeking a ban on sale of weight loss drugs that are still undergoing clinical trials ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results